Gut

Following a Mediterranean diet is linked to lower risk of developing Crohn's disease later in life

Updated

Abstract

Higher adherence to a Mediterranean diet is associated with a 42% lower risk of later-onset Crohn's disease.

  • A total of 164 cases of Crohn's disease and 395 cases of ulcerative colitis were confirmed among 83,147 participants over an average follow-up of 17 years.
  • Participants with higher Mediterranean diet adherence scores had a lower risk of developing Crohn's disease compared to those with the lowest scores.
  • No significant association was found between Mediterranean diet adherence and the risk of developing ulcerative colitis.
  • The prevalence of poor adherence to the Mediterranean diet was 27%, contributing to a population attributable risk of 12% for later-onset Crohn's disease.
  • The associations observed were consistent across various demographic factors such as age and sex.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interests: HK receives consulting fees from Abbvie. HK also receives grant support from Takeda and Pfizer. ATC receives consulting fees from Janssen, Pfizer and Bayer Pharma AG. SC has received consulting fees from Abbvie, Takeda and Ferring. OO has been Principal Investigaor (PI) on projects at Karolinska Institutet partly financed by investigator-initiated grants from Janssen, Ferring, Takeda and Pfizer. None of those studies have any relation to this study. Karolinska Institutet has received fees for OO's lectures and participation on advisory boards from Janssen, Ferring, Takeda and Pfizer regarding topics not related to this study. OO was supported by grants from the Swedish Medical Society (Project grants; Fund for Research in Gastroenterology; and Ihre Foundation), Mag-tarmfonden, Karolinska Institutet Foundations, Swedish Foundation for Strategic Research and Regional Agreement on Medical Training and Clinical Research between Stockholm County Council and Karolinska Institutet. JFL coordinates a study on behalf of the Swedish IBD quality register (SWIBREG). This study has received funding from Janssen.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free